详情页

资源类型：

文章类型：

作者：

Wang, Baocheng[1] * ; Zhou, Caicun[2] ; Wang, Jun[3] ; Hu, Jie[4] ; Duan, Jianchun[5] ; Yao, Yu[6] ; Li, Guohui[7] ; Fan, Yun[8] ; Huang, Cheng[9] ; Chu, Qian[10] ; Liu, Chunling[11] ; Liu, Lihua[12]

; Ma, Zhiyong[13] ; Pan, Yueyin[14] ; Su, ChunXia[15] ; Shu, Yongqian[16] ; Wang, Yongsheng[17] ; Zhou, Chengzhi[18] ; Zhao, Mingfang[19] ; Zhang, Xiaotao[20] ;

机构： [1]No. 960 Hospital, The People’s Liberation Army, Jinan, NA, China [2]Department of Medical Oncology, Shanghai Pulmonary Hospital, Thoracic Cancer Institute, Tongji University School of Medicine, Shanghai, China [3]Department of Oncology, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Jinan, China [4]Zhongshan Hospital, Fudan University, Shanghai, China [5]State Key Laboratory of Molecular Oncology, Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China [6]First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, China [7]Department of Pharmacy, Cancer Hospital of Chinese Academy of Medical Sciences, Beijing, China., Beijing, China [8]Zhejiang Cancer Hospital, Hangzhou, Zhejiang, China [9]Fujian Cancer Hospital, Fujian, China [10]Tongji Hospital, Tongji Medical College Huazhong University of Science and Technology, Wuhan, China [11]The Affiliated Tumor Hospital of Xinjiang Medical University, Urumqi, China [12]The Fourth Hospital of Hebei Medical University, Shijiazhuang, China [13]Henna Cancer Hosptal, Zhengzhou, China [14]Anhui Provincial Hospital, Hefei, China [15]Oncology Department, Shanghai Pulmonary Hospital, Shanghai, China [16]Jiangsu Province Hospital, Nanjing, China [17]Clinical Trial Center, West China Hospital, Sichuan University, Chengdu, China [18]State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, the First Aff, Guangzhou, China [19]Department of Medical Oncology, The First Hospital of China Medical University, Shenyang, China [20]Qingdao Center Hospital, Qiangdao, China

出处：

ISSN：

语种：

WOS：

中科院分区：

出版当年[2025]版：

大类 | 1 区

医学

小类 | 1 区肿瘤学

最新[2025]版：

大类 | 1 区

医学

小类 | 1 区肿瘤学

JCR分区：

出版当年[2024]版：

Q1 ONCOLOGY

最新[2024]版：

Q1 ONCOLOGY

第一作者：

第一作者机构： [1]No. 960 Hospital, The People’s Liberation Army, Jinan, NA, China

推荐引用方式(GB/T 7714)：

APA：

MLA：

Current status of PD-(L)1 inhibitor usage in advanced or metastatic non-small cell lung cancer: A national survey of oncologists in China

文献详情